- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4965 - Non-condensed pyrazines
Patent holdings for IPC class A61K 31/4965
Total number of patents in this class: 1816
10-year publication summary
|
96
|
95
|
113
|
128
|
126
|
164
|
139
|
127
|
83
|
67
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10849 |
49 |
| Nippon Shinyaku Co., Ltd. | 325 |
44 |
| Actelion Pharmaceuticals Ltd | 530 |
38 |
| Parion Sciences, Inc. | 61 |
35 |
| Vertex Pharmaceuticals Incorporated | 1597 |
28 |
| FUJIFILM Toyama Chemical Co., Ltd. | 111 |
22 |
| F. Hoffmann-La Roche AG | 7925 |
20 |
| AstraZeneca AB | 2909 |
19 |
| Morehouse School of Medicine | 155 |
19 |
| Janssen Pharmaceutica N.V. | 3392 |
18 |
| Guangzhou Magpie Pharmaceuticals Co., Ltd. | 29 |
18 |
| Bristol-myers Squibb Company | 4898 |
17 |
| Boehringer Ingelheim International GmbH | 4650 |
17 |
| Medibeacon, Inc. | 136 |
17 |
| Toyama Chemical Co., Ltd. | 102 |
17 |
| Abbvie Inc. | 1800 |
16 |
| Merck Sharp & Dohme LLC | 3748 |
16 |
| Dana-Farber Cancer Institute, Inc. | 2571 |
15 |
| The Regents of the University of California | 19918 |
13 |
| Merck Sharp & Dohme Corp. | 2194 |
12 |
| Other owners | 1366 |